How best to manage gastrointestinal stromal tumor

doi:10.5306/wjco.v8.i2.135

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9792)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

554

WORD

371

HTML

3879

Figures (1-1)

262

Sum=5066

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

922

Download

1628

Sum=2550

Publishing Process of This Article

Item

Count

Browse

962

Download

1214

Sum=2176

Apr 10, 2017 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Apr 10, 2017; 8(2): 135-144
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.135

Open in New Tab Full Size Figure Download Figure

Figure 1 Pathogenesis. GIST: Gastrointestinal stromal tumor; PDGFRA: Platelet derived growth factor receptor-alpha; HIF: Hypoxia inducible factors.

Citation: Lanke G, Lee JH. How best to manage gastrointestinal stromal tumor. World J Clin Oncol 2017; 8(2): 135-144
URL: https://www.wjgnet.com/2218-4333/full/v8/i2/135.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i2.135